Form 4 Filing for Russell Skibsted

Russell Skibsted, Chief Financial Officer of Processa Pharmaceuticals, Inc. (PCSA), acquired 2,190 shares of common stock on April 30, 2026. The transaction was executed at a price of $2.69 per share. Following this acquisition, Skibsted directly owns 6,498 shares of the company's common stock. The filing, dated May 1, 2026, indicates a non-derivative transaction where shares were acquired.